Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Shenghong Wei"'
Autor:
Zaisheng Ye, Shenghong Wei, Yi Zeng, Yi Wang, Zhitao Lin, Shu Chen, Yunqing Xie, Qiuhong Zheng, Luchuan Chen
Publikováno v:
BMC Surgery, Vol 21, Iss 1, Pp 1-7 (2021)
Abstract Aim This study was designed to investigate the prognostic effect of preoperative body mass index (BMI) for Type 2 diabetes mellitus (T2DM) patients with non-metastasis gastric cancer (GC) who underwent D2 gastrectomy. Methods T2DM patients w
Externí odkaz:
https://doaj.org/article/ac51ecbd18704d5aaa037b4ce5a7ffa6
Autor:
Zaisheng Ye, Yi Zeng, Shenghong Wei, Yi Wang, Zhitao Lin, Shu Chen, Zhiwei Wang, Shanshan Chen, Luchuan Chen
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-8 (2021)
Abstract Background We conducted a single-arm phase II trial to investigate the short-term efficacy and safety of apatinib combined with oxaliplatin and S-1 in the treatment of unresectable gastric cancer. Patients and methods Previously untreated pa
Externí odkaz:
https://doaj.org/article/8b5c67b7bbec4117a9724c8032686c10
Autor:
Xiaopeng Wang, Ruirong Lin, Yi Zeng, Yi Wang, Shenghong Wei, Zhitao Lin, Shu Chen, Zaisheng Ye, Luchuan Chen
Publikováno v:
Frontiers in Genetics, Vol 13 (2022)
Background: Mining the prognostic biomarkers of colorectal cancer (CRC) has important clinical and scientific significance. The role of Fc receptor-like B (FCRLB) in solid tumors has never been reported or studied to our knowledge, and the prognostic
Externí odkaz:
https://doaj.org/article/9855dbc3ccc642b6ad8f798fe23ad896
Autor:
Zaisheng Ye, Miao Zheng, Yi Zeng, Shenghong Wei, Yi Wang, Zhitao Lin, Chen Shu, Yunqing Xie, Qiuhong Zheng, Luchuan Chen
Publikováno v:
Frontiers in Genetics, Vol 13 (2022)
Externí odkaz:
https://doaj.org/article/05e5a91da91543bfb46a08014a930396
Autor:
Zaisheng Ye, Miao Zheng, Yi Zeng, Shenghong Wei, He Huang, Yi Wang, Qinying Liu, Zhitao Lin, Shu Chen, Qiuhong Zheng, Luchuan Chen
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Patients with advanced stomach adenocarcinoma (STAD) commonly show high mortality and poor prognosis. Increasing evidence has suggested that basic metabolic changes may promote the growth and aggressiveness of STAD; therefore, identification of metab
Externí odkaz:
https://doaj.org/article/9d652b5b98934a33a2d11951a5cf0dd6
Autor:
Zaisheng Ye, Miao Zheng, Yi Zeng, Shenghong Wei, Yi Wang, Zhitao Lin, Chen Shu, Yunqing Xie, Qiuhong Zheng, Luchuan Chen
Publikováno v:
Frontiers in Genetics, Vol 11 (2020)
Cancer stem cells (CSCs), characterized by infinite proliferation and self-renewal, greatly challenge tumor therapy. Research into their plasticity, dynamic instability, and immune microenvironment interactions may help overcome this obstacle. Data o
Externí odkaz:
https://doaj.org/article/7944167786da429fbc81d4c3b9c66a37
Autor:
Yi Zeng, Shenghong Wei, Shu Chen, Zhouwei Zhan, Yi Wang, Zhiwei Wang, Hang Chen, Luchuan Chen, Zaisheng Ye
Publikováno v:
Journal of Gastrointestinal Surgery. 27:887-894
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 8, Iss 15, Pp 6768-6779 (2019)
Cancer Medicine, Vol 8, Iss 15, Pp 6768-6779 (2019)
HOTAIR, a well‐known long noncoding RNAs (lncRNA), has been recognized to contribute to the tumor metastasis in several tumors. But its role in gastric cancer remains elusive. Here, we reported an increase in HOTAIR promoted proliferation and metas
Autor:
Yi Wang, Qinying Liu, Luchuan Chen, Yi Zeng, Zaisheng Ye, Shu Chen, Shenghong Wei, Zheng Qiuhong, Zhitao Lin, Miao Zheng, He Huang
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology
Frontiers in Oncology
Patients with advanced stomach adenocarcinoma (STAD) commonly show high mortality and poor prognosis. Increasing evidence has suggested that basic metabolic changes may promote the growth and aggressiveness of STAD; therefore, identification of metab
Autor:
Shu Chen, Zaisheng Ye, Yunqing Xie, Yi Wang, Shenghong Wei, Qiuhong Zheng, Luchuan Chen, Zhitao Lin, Yi Zeng
Publikováno v:
BMC Surgery, Vol 21, Iss 1, Pp 1-7 (2021)
BMC Surgery
BMC Surgery
Aim This study was designed to investigate the prognostic effect of preoperative body mass index (BMI) for Type 2 diabetes mellitus (T2DM) patients with non-metastasis gastric cancer (GC) who underwent D2 gastrectomy. Methods T2DM patients with pT1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47bd38c444420963fc0d1138a87a58a9
https://doi.org/10.21203/rs.3.rs-330099/v1
https://doi.org/10.21203/rs.3.rs-330099/v1